[Atraucan, a new needle for spinal analgesia]

Area of Science:

• Anesthesiology
• Neurosurgery
• Pain Management

Background:

• Spinal analgesia is a common procedure for lower body surgeries.
• Choosing the appropriate spinal needle is crucial for patient outcomes and minimizing complications.
• Post-dural puncture headache (PDPH) is a known complication of spinal anesthesia.

Purpose of the Study:

• To compare the incidence of post-dural puncture headache (PDPH) between Sprotte 24G and Atraucan 26G spinal needles.
• To evaluate the efficacy and safety of these two spinal needles in patients under 40 undergoing lower body surgery.

Main Methods:

• A randomized controlled trial involving 106 patients under 40 years old scheduled for lower body surgery.
• Patients received spinal analgesia using either a Sprotte 24G or an Atraucan 26G spinal needle.
• Outcomes assessed included incidence of insufficient blocks, PDPH, and need for epidural blood patch.

Main Results:

• Higher incidences of insufficient blocks were observed with the Atraucan needle.
• Nineteen patients reported PDPH, with a significantly higher proportion experiencing it in the Atraucan group (18 patients) compared to the Sprotte group (3 patients).
• Eight patients (16%), all in the Atraucan group, required an epidural blood patch; needle insertion ease and puncture attempts were similar for both needles.

Conclusions:

• The Atraucan 26G spinal needle is associated with a significantly higher incidence of PDPH in young patients undergoing spinal analgesia.
• Due to the increased risk of PDPH and the need for epidural blood patches, the Atraucan 26G needle is not recommended for this patient population.
• The Sprotte 24G needle appears to be a safer alternative, associated with a lower incidence of PDPH.